FDI Submits Application to FDA for Approval of MESOMARK

Fujirebio Diagnostics (FDI), a company specializing in oncology testing, announced that it submitted a 510(k) application to the FDA for clearance of MESOMARK, the first blood test for mesothelioma.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=517506XSL_NEWSML_TO_NEWSML_WEB.xml)

(http://www.genengnews.com/news/bnitem.aspx?name=517506XSL_NEWSML_TO_NEWSML_WEB.xml)